/

MDGL

Madrigal Pharmaceuticals, Inc.Open

453.88−13.28 −2.84%USD

NasdaqGS · as of Oct 13, 11:21 ET · 15m delay

Open

467.16

Prev close

467.16

Day range

453.43467.27

52-week range

393.61615.00

Volume

51.63K0.18×

Mkt cap

10.49B

P/E ttm

—

Fwd P/E

47.16

EPS ttm

-12.85

Div yield

0.00%

Earnings

Jul 30, 2026

From 52w high

−26.20%

Price Chart

Yahoo Finance · delayed

MDGLOct 13, 2026O 467.16H 467.27L 453.42C 453.88−13.28 (−2.84%)Vol 51.63K

SMA 50517.73
SMA 200507.13

1Y change +5.65% since Oct 10, 2025 close540 bars loadedTimes in America/New_YorkDraw from the left toolbar · click a drawing to edit · right-click for alerts and export

MDGL Madrigal Pharmaceuticals, Inc. · Last Guard Finance

SEAS

Seasonality · MDGL

2007–2026 · monthly returns

Strongest month Dec +23.10%Weakest month Jun −5.41%Averages use completed years only. Past seasonality doesn't predict future returns.

Year	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec	Year
2026	-16.0	-11.7	21.2	-1.2	-3.9	8.0	-13.0	15.6	-6.7	-9.9			−22.1%
2025	8.5	1.9	-2.9	0.8	-17.6	9.9	-0.0	44.7	4.8	-8.7	42.5	-2.5	+88.7%
2024	-6.3	9.0	13.1	-23.6	15.8	18.6	1.6	-13.2	-14.1	22.2	26.5	-6.0	+33.4%
2023	-0.7	-6.0	-10.6	28.8	-10.8	-17.0	-11.1	-12.3	-18.9	-10.0	54.7	13.8	−20.3%
2022	-32.1	61.3	5.7	-28.7	-5.2	7.8	-12.2	14.8	-9.9	9.0	-1.0	314.0	+242.5%
2021	6.8	2.0	-3.5	16.4	-17.5	-13.3	-10.4	-5.2	-3.6	-2.6	6.4	2.5	−23.8%
2020	-8.9	3.8	-22.5	25.3	38.6	-2.4	-9.4	5.0	10.2	7.2	-8.2	-4.8	+22.0%
2019	2.7	13.4	-4.6	-15.3	-12.9	13.4	-16.7	6.2	-7.0	7.2	19.8	-17.7	−19.2%
2018	61.7	-15.1	-7.3	-3.1	134.7	5.3	-8.1	-6.9	-10.5	-10.9	-39.4	-2.5	+22.8%
2017	2.6	2.1	-1.3	7.1	-7.8	6.8	-4.7	10.2	163.3	11.1	0.7	82.3	+516.0%
2016	-31.4	-4.2	4.3	66.7	-12.5	-25.7	-17.6	53.9	9.9	30.1	-3.0	-6.9	+21.6%
2015	-10.2	0.8	-19.2	16.0	-4.9	4.2	-4.9	-5.7	-13.0	-61.5	-35.8	-18.6	−86.8%
2014	1.9	15.7	-30.3	-2.3	-2.6	-0.2	-3.4	1.3	-24.8	-1.7	7.1	-16.4	−49.4%
2013	24.2	-23.3	0.1	19.2	-28.0	-32.4	34.5	-12.1	6.9	-28.1	11.7	3.4	−41.9%
2012	-1.3	3.7	-8.2	-0.9	10.6	13.7	34.4	-10.6	16.0	3.3	2.5	11.8	+93.1%
2011	-18.5	12.0	-5.9	15.4	-6.1	-11.8	-7.2	-9.0	-23.5	13.8	13.2	11.5	−23.7%
2010	-17.4	-6.5	10.2	-5.8	-22.9	-13.7	18.9	-13.7	44.0	-7.3	15.9	42.7	+20.9%
2009	43.8	-84.5	57.4	51.9	28.0	-44.0	12.9	7.6	9.5	-11.3	44.7	27.1	−17.3%
2008	17.6	12.4	-8.7	-17.1	4.3	-12.9	29.0	12.6	-14.0	-7.1	-25.1	15.5	−8.7%
2007			-5.4	1.0	12.3	-9.3	-4.3	-24.7	10.4	27.6	-11.5	-10.1	−21.5%

INSD

Insider Activity · MDGL

Market-wide insider buying →Congress trades →SEC Form 4 filings via Yahoo Finance

Buys, 6 months

54.7K shares

Sells, 6 months

21.3K shares

Net shares

+33.4K

Net change in insider shares

+2.50%

Date	Insider	Transaction	Shares	Value
Sep 10, 2026	Sibold William JohnChief Executive Officer	Sale at price 527.88 - 546.38 per share.	11.6K	$6.24M
Aug 16, 2026	Kelley Shannon TGeneral Counsel	Sale at price 514.97 per share.	664	$341.94K
Aug 13, 2026	Reed John CDirector	Stock Award(Grant) at price 0.00 per share.	647	—
Jul 19, 2026	Sibold William JohnChief Executive Officer	Sale at price 542.75 - 555.05 per share.	2.5K	$1.37M
Jul 16, 2026	Sibold William JohnChief Executive Officer	—	50K	—
Jun 16, 2026	Fouse Jacqualyn A.Director	Stock Award(Grant) at price 0.00 per share.	454	—
Jun 16, 2026	Taub Rebecca A.Director	Stock Award(Grant) at price 0.00 per share.	454	—
Jun 16, 2026	Levy Richard SDirector	Stock Award(Grant) at price 0.00 per share.	454	—
Jun 16, 2026	Daly James M.Director	Stock Award(Grant) at price 0.00 per share.	454	—
Jun 16, 2026	Brennan Daniel JDirector	Stock Award(Grant) at price 0.00 per share.	404	—
Jun 16, 2026	Baker Bros Advisors, L.P.Unknown	Stock Award(Grant) at price 0.00 per share.	1.8K	—
May 21, 2026	Levy Richard SDirector	Sale at price 506.68 - 519.98 per share.	5.7K	$2.93M
May 17, 2026	Soergel DavidOfficer	Sale at price 515.90 per share.	844	$435.42K
Mar 5, 2026	Taub Rebecca A.Director	Sale at price 431.94 per share.	491	$212.08K
Mar 5, 2026	Sibold William JohnChief Executive Officer	Sale at price 431.94 per share.	1.7K	$718.32K
Mar 5, 2026	Dier Mardi CChief Financial Officer	Sale at price 425.08 - 437.65 per share.	2K	$853.99K
Mar 5, 2026	Huntsman Carole AOfficer	Sale at price 431.94 per share.	419	$180.98K
Mar 5, 2026	Kelley Shannon TGeneral Counsel	Sale at price 431.94 per share.	360	$155.50K
Mar 3, 2026	Sibold William JohnChief Executive Officer	Stock Award(Grant) at price 0.00 per share.	15K	—
Mar 3, 2026	Dier Mardi CChief Financial Officer	Stock Award(Grant) at price 0.00 per share.	5.2K	—

13F

Investors Holding MDGL

latest 13F filings of 29 followed managers

Investors holding MDGL
Investor	Value	Of portfolio	Shares	Change	Quarter
Paulson & Co. · John Paulson	$719.5M	27.9%	1.34M	−3.7%	Q2 2026
Renaissance Technologies	$24.7M	0.03%	45.94K	−36%	Q2 2026

From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors

MDGL

Price Chart

Keyboard shortcuts & functions

Anywhere

Command line

Charts (click the chart first)

Function codes

MDGL

Price Chart

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About Madrigal Pharmaceuticals, Inc.

Seasonality · MDGL

Insider Activity · MDGL

Congress Trades · MDGL

Investors Holding MDGL

Investors Holding MDGL

Congress Trades · MDGL

Insider Activity · MDGL

Seasonality · MDGL

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About Madrigal Pharmaceuticals, Inc.

Financial Snapshot

Earnings & Dividends

News